Final Results of a Prospective Phase 2 Study of Adding Erlotinib to Chemoradiation for patients With Stage III Non-small Cell Lung Cancer

被引：0
作者：
Komaki, R. U. [1 ]
Allen, P. K. [1 ]
Wei, X. [1 ]
Blumenschein, G. R. [2 ]
XiMing, T. [3 ]
Lee, J. J. [3 ]
Welsh, J. W. [1 ]
Wistuba, I. [4 ]
Liu, D. D. [3 ]
Meyn, R. [5 ]
Hong, W. K. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Thorac Med Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1725
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3113
引用
收藏
页码：E470 / E470
页数：1
相关论文
共 50 条
  • [31] Stage III Non-small Cell Lung Cancer
    Rusch, Valerie W.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 727 - 735
  • [32] Comparison of chemoradiation and radiation therapy alone in patients with stage III unresectable non-small cell lung cancer
    Ahn, S
    Kim, Y
    Kim, K
    Na, K
    Kim, Y
    Bom, H
    Park, K
    LUNG CANCER, 2005, 49 : S164 - S165
  • [33] Pathological response and prognosis of stage III non-small cell lung cancer patients treated with induction chemoradiation
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Sakaguchi, Shinji
    Sato, Fumitomo
    Takahashi, Shoji
    Sato, Keita
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Mitsuda, Aki
    Terahara, Atsuro
    Shibuya, Kazutoshi
    Takagi, Keigo
    Homma, Sakae
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (03) : 260 - 266
  • [34] Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study
    Blanco, Remei
    Sole, Josep
    Montesinos, Jesus
    Mesia, Carlos
    Algara, Manuel
    Terrassa, Josefa
    Gay, Monserrat
    Domenech, Monserrat
    Bastus, Roma
    Bover, Isabel
    Nogue, Miquel
    Vadell, Catalina
    LUNG CANCER, 2008, 62 (01) : 62 - 71
  • [35] Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small cell lung cancer: Results of a phase 1/2 trial: Comment
    Chang, Joe Y.
    International Journal of Radiation Oncology Biology Physics, 2013, 87 (01): : 2 - 4
  • [36] Neoadjuvant combined treatment for stage III non-small cell lung cancer (NSCLC): Results of a prospective phase II trial
    Thomas, M
    Rube, C
    Semik, M
    Klinke, F
    VonEiff, M
    VandeLoo, J
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 431 - 433
  • [37] The Outcome and Adverse Event of Chemoradiation ± Surgery for Stage III Non-Small Cell Lung Cancer
    Kudo, Shigehiro
    Saito, Yoshihiro
    Ushijima, Hiroki
    Okubo, Yu
    Kazumoto, Tomoko
    Saito, Jun-Ichi
    Mizutani, Hideaki
    Yamane, Yuki
    Sudo, Junko
    Kurimoto, Futoshi
    Sakai, Hiroshi
    Nakajima, Yuki
    Kinoshita, Hiroyasu
    Akiyama, Hirohiko
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1035 - S1036
  • [38] Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer
    Cardenal, Felipe
    Arnaiz, Maria Dolores
    Moran, Teresa
    Jove, Josep
    Nadal, Ernest
    Porta, Ruth
    Sole, Josep Maria
    Brao, Isabel
    Palmero, Ramon
    Fuentes, Rafael
    Nunez, Inmaculada
    Caveda, Elena
    Cassinello, Alejo
    LUNG CANCER, 2011, 74 (01) : 69 - 74
  • [39] A Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Unresectable Stage III Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S569 - S570
  • [40] A Phase II Study of Erlotinib as Initial Treatment for Patients with Stage IIIB-IV Non-small Cell Lung Cancer
    Akerley, Wallace
    Boucher, Kenneth M.
    Bentz, Joel S.
    Arbogast, Kylee
    Walters, Theodore
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 214 - 219
12345